This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Jan 17;368(3):290.

doi: 10.1056/NEJMc1214183.

Linezolid for extensively drug-resistant tuberculosis

Ernesto Jaramillo, Karin Weyer, Mario Raviglione

PMID: 23323917
DOI: 10.1056/NEJMc1214183

Comment

Linezolid for extensively drug-resistant tuberculosis

Ernesto Jaramillo et al. N Engl J Med. 2013.

. 2013 Jan 17;368(3):290.

doi: 10.1056/NEJMc1214183.

Authors

Ernesto Jaramillo, Karin Weyer, Mario Raviglione

PMID: 23323917
DOI: 10.1056/NEJMc1214183

No abstract available

PubMed Disclaimer

Comment on

Linezolid for treatment of chronic extensively drug-resistant tuberculosis.
Lee M, Lee J, Carroll MW, Choi H, Min S, Song T, Via LE, Goldfeder LC, Kang E, Jin B, Park H, Kwak H, Kim H, Jeon HS, Jeong I, Joh JS, Chen RY, Olivier KN, Shaw PA, Follmann D, Song SD, Lee JK, Lee D, Kim CT, Dartois V, Park SK, Cho SN, Barry CE 3rd. Lee M, et al. N Engl J Med. 2012 Oct 18;367(16):1508-18. doi: 10.1056/NEJMoa1201964. N Engl J Med. 2012. PMID: 23075177 Free PMC article. Clinical Trial.

Similar articles

Linezolid for extensively drug-resistant tuberculosis.
Cattaneo D, Orlando G, Cordier L. Cattaneo D, et al. N Engl J Med. 2013 Jan 17;368(3):291. doi: 10.1056/NEJMc1214183. N Engl J Med. 2013. PMID: 23323919 No abstract available.
Linezolid for extensively drug-resistant tuberculosis.
Dhooria S, Agarwal R, Behera D. Dhooria S, et al. N Engl J Med. 2013 Jan 17;368(3):290-1. doi: 10.1056/NEJMc1214183. N Engl J Med. 2013. PMID: 23323918 No abstract available.
Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence.
Sotgiu G, Centis R, D'Ambrosio L, Spanevello A, Migliori GB; International Group for the study of Linezolid. Sotgiu G, et al. Eur Respir J. 2013 Jul;42(1):288-90. doi: 10.1183/09031936.00191712. Eur Respir J. 2013. PMID: 23813314 No abstract available.
[The analysis of clinical data about the treatment of linezolid against tuberculosis].
Nie WJ, Chu NH. Nie WJ, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2013 Aug;36(8):601-3. Zhonghua Jie He He Hu Xi Za Zhi. 2013. PMID: 24252739 Review. Chinese. No abstract available.
Linezolid.
[No authors listed] [No authors listed] Tuberculosis (Edinb). 2008 Mar;88(2):122-5. doi: 10.1016/S1472-9792(08)70014-3. Tuberculosis (Edinb). 2008. PMID: 18486048 Review. No abstract available.

See all similar articles

Cited by

Linezolid Induced Twice Pure Red Cell Aplasia in a Patient with Central Nervous System Infection after Allogeneic Stem Cell Transplantation.
Hu W, Shi B, Liu L, He S, Ye L, Tian D, Zhang Y. Hu W, et al. Iran J Pharm Res. 2016 Spring;15(2):647-51. Iran J Pharm Res. 2016. PMID: 27642338 Free PMC article.
Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysis.
Agyeman AA, Ofori-Asenso R. Agyeman AA, et al. Ann Clin Microbiol Antimicrob. 2016 Jun 22;15(1):41. doi: 10.1186/s12941-016-0156-y. Ann Clin Microbiol Antimicrob. 2016. PMID: 27334498 Free PMC article.
Linezolid for drug-resistant pulmonary tuberculosis.
Singh B, Cocker D, Ryan H, Sloan DJ. Singh B, et al. Cochrane Database Syst Rev. 2019 Mar 20;3(3):CD012836. doi: 10.1002/14651858.CD012836.pub2. Cochrane Database Syst Rev. 2019. PMID: 30893466 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations